File(s) not publicly available
The politics and bio-ethics of regulatory trust
journal contribution
posted on 2023-06-08, 06:59 authored by John AbrahamDrawing on case studies from the modern era of pharmaceutical regulation in the UK, US and Europe, I examine how the extent and distribution of trust between regulators, the pharmaceutical industry, and the medical profession about drug testing and monitoring influences knowledge and regulatory judgements about the efficacy and safety of prescription drugs. Introducing the concepts of `acquiescent and `investigative norms of regulatory trust, I demonstrate how investigative norms of regulatory trustwhich deter pharmaceutical companies from assuming that their data analyses will be accepted without independent de-construction-drive up bioethical and regulatory standards of drug assessment in the interests of health. By contrast, acquiescent norms of regulatory trust, which are associated with industrial capture and professional closure of interests, promote permissive standards allowing patients to take pharmaceuticals with greater risks to health and less evidence of therapeutic efficacy.
History
Publication status
- Published
Journal
Medicine, Health Care and PhilosophyISSN
1386-7423Publisher
KluwerExternal DOI
Issue
4Volume
11Page range
415-426Pages
12.0Department affiliated with
- Sociology and Criminology Publications
Full text available
- No
Peer reviewed?
- Yes
Legacy Posted Date
2012-02-06Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC